1. Schellinger PD, Meinck HM, Thron A: Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 1999, 44:275–281.
2. Yuh WT, Fisher DJ, Runge VM, et al.: Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. AJNR Am J Neuroradiol 1994, 15:1037–1051.
3. Yuh WT, Tali ET, Nguyen HD, et al.: The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 1995, 16:373–380.
4. Sze G, Johnson C, Kawamura Y, et al.: Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol 1998, 19:821–828.
5. Mayr NA, Yuh WT, Muhonen MG, et al.: Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. AJNR Am J Neuroradiol 1994, 15:1053–1061.